Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey W Coombs

Showing results (31-40 of 172) with videos related to

Pageof 18
Sort By:
Molecular and Cellular Probes|December 7, 2013
Development and usage of protein microarrays for the quantitative measurement of Panton-Valentine leukocidinBettina Stieber, Stefan Monecke, Elke Müller, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2015
A clonal complex 12 methicillin-resistant Staphylococcus aureus strain, West Australian MRSA-59, harbors a novel pseudo-SCCmec elementStefan Monecke, Geoffrey W Coombs, Julie Pearson, et al.
BMC Research Notes|December 24, 2013
Genome sequencing and molecular characterisation of Staphylococcus aureus ST772-MRSA-V, "Bengal Bay Clone"Stefan Monecke, Vico Baier, Geoffrey W Coombs, et al.
Communicable Diseases Intelligence (2018)|December 17, 2024
Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP) Bloodstream Infection Annual Report 2023Geoffrey W Coombs, Denise A Daley, Princy Shoby, et al.
Communicable Diseases Intelligence (2018)|March 18, 2020
Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2018Geoffrey W Coombs, Denise A Daley, Shakeel Mowlaboccus, et al.
Communicable Diseases Intelligence (2018)|March 18, 2020
Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Sepsis Outcome Programme (AESOP) Annual Report 2018Geoffrey W Coombs, Denise A Daley, Shakeel Mowlaboccus, et al.
The Journal of Antimicrobial Chemotherapy|June 20, 2006
Molecular typing of methicillin-resistant staphylococci isolated from cats and dogsSeidu Malik, Geoffrey W Coombs, Frances G O'Brien, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 6, 2003
Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, AustraliaWendy J Munckhof, Jacqueline Schooneveldt, Geoffrey W Coombs, et al.
Journal of Clinical Microbiology|March 24, 2012
A multidrug-resistant Staphylococcus epidermidis clone (ST2) is an ongoing cause of hospital-acquired infection in a Western Australian hospitalMicael Widerström, Cheryll A McCullough, Geoffrey W Coombs, et al.
Communicable Diseases Intelligence (2018)|April 26, 2022
Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2020Geoffrey W Coombs, Denise A Daley, Nicholas W T Yee, et al.
Pageof 18

Showing results (31-40 of 172) with videos related to

Sort By:
Pageof 18
Molecular and Cellular Probes|December 7, 2013
Development and usage of protein microarrays for the quantitative measurement of Panton-Valentine leukocidinBettina Stieber, Stefan Monecke, Elke Müller, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2015
A clonal complex 12 methicillin-resistant Staphylococcus aureus strain, West Australian MRSA-59, harbors a novel pseudo-SCCmec elementStefan Monecke, Geoffrey W Coombs, Julie Pearson, et al.
BMC Research Notes|December 24, 2013
Genome sequencing and molecular characterisation of Staphylococcus aureus ST772-MRSA-V, "Bengal Bay Clone"Stefan Monecke, Vico Baier, Geoffrey W Coombs, et al.
Communicable Diseases Intelligence (2018)|December 17, 2024
Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP) Bloodstream Infection Annual Report 2023Geoffrey W Coombs, Denise A Daley, Princy Shoby, et al.
Communicable Diseases Intelligence (2018)|March 18, 2020
Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2018Geoffrey W Coombs, Denise A Daley, Shakeel Mowlaboccus, et al.
Communicable Diseases Intelligence (2018)|March 18, 2020
Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Sepsis Outcome Programme (AESOP) Annual Report 2018Geoffrey W Coombs, Denise A Daley, Shakeel Mowlaboccus, et al.
The Journal of Antimicrobial Chemotherapy|June 20, 2006
Molecular typing of methicillin-resistant staphylococci isolated from cats and dogsSeidu Malik, Geoffrey W Coombs, Frances G O'Brien, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 6, 2003
Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, AustraliaWendy J Munckhof, Jacqueline Schooneveldt, Geoffrey W Coombs, et al.
Journal of Clinical Microbiology|March 24, 2012
A multidrug-resistant Staphylococcus epidermidis clone (ST2) is an ongoing cause of hospital-acquired infection in a Western Australian hospitalMicael Widerström, Cheryll A McCullough, Geoffrey W Coombs, et al.
Communicable Diseases Intelligence (2018)|April 26, 2022
Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2020Geoffrey W Coombs, Denise A Daley, Nicholas W T Yee, et al.
Pageof 18